Hosted on MSN1d
Astellas seeks conditional approval for GA treatment in Japan
Astellas Pharma has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare seeking ...
LancasterOnline2d
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their spinal cord. On Wednesday, researchers reported that a spine-stimulating im ...
Le Lézard2d
Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan
Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...
optometryadvisor3d
Reading Metrics Reveal Progressive Functional Decline in Geographic Atrophy
Two reading metrics outperform 2 existing reading metrics for determining functional decline in patients with geographic atrophy.
Taiwan News3d
Vietnam Spinal Muscular Atrophy Treatment Market Beyond the Known Unveiling Uncharted Territory Techniques for Research Excellence
Request To Download Free Sample of This Strategic Report @ Introduction Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the progressive loss of motor neurons, leading to ...